The clinical outcome of end-stage renal disease patients who return to peritoneal dialysis after renal allograft failure

K. S. Yang, J. I. Kim, I. S. Moon, B. S. Choi, C. W. Park, C. W. Yang, YuSeun Kim, B. H. Chung

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background With the increased numbers of kidney transplantations, more patients return to dialysis after graft loss (DAGL). The aim of this study was to investigate the safety and efficacy of peritoneal dialysis (PD) after graft loss compared with transplant-naive PD patients (TN-PD). Method This study was conducted on 715 patients who started PD between 1988 and 2009, including 47 who started PD after allograft loss (DAGL-PD) and 668 in the (TN-PD) group. Result The mean ages were 40.8 ± 10.7 in DAGL-PD group and 51.03 ± 14.20 in TN-PD group (P <.01). The most common cause of end-stage renal disease in DAGL was primary glomerulonephritis (76.6%), but it was diabetes mellitus (38.9%) in the TN-PD group (P <.05). Patient survival rates at 1, 5, and 10 years were not different: 100%, 86%, and 57% versus 91%, 70%, and 62%, respectively. PD survival rate at 1, 5, and 10 years did not show significant differences: 98%, 95%, and 88% versus 95%, 80%, and 66%, respectively. The most common causes of death in both groups were infection (DAGL, 26.7%; TN-PD, 24.5%) followed by cardiovascular disease (DAGL, 20.0%; TN-PD, 19.6%); the distribution of causes did not differ significantly (P >.05). Conclusion The clinical outcomes of PD in DAGL group were comparable with those of TN-PD patients. Therefore, PD could be considered as a dialysis modality for patients who experience allograft failure.

Original languageEnglish
Pages (from-to)2949-2952
Number of pages4
JournalTransplantation Proceedings
Volume45
Issue number8
DOIs
Publication statusPublished - 2013 Oct 1

Fingerprint

Peritoneal Dialysis
Chronic Kidney Failure
Renal Insufficiency
Allografts
Transplants
Dialysis
Kidney Transplantation
Safety

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Cite this

Yang, K. S. ; Kim, J. I. ; Moon, I. S. ; Choi, B. S. ; Park, C. W. ; Yang, C. W. ; Kim, YuSeun ; Chung, B. H. / The clinical outcome of end-stage renal disease patients who return to peritoneal dialysis after renal allograft failure. In: Transplantation Proceedings. 2013 ; Vol. 45, No. 8. pp. 2949-2952.
@article{7ce0ba41a69845e9a7eb71fdca57cedc,
title = "The clinical outcome of end-stage renal disease patients who return to peritoneal dialysis after renal allograft failure",
abstract = "Background With the increased numbers of kidney transplantations, more patients return to dialysis after graft loss (DAGL). The aim of this study was to investigate the safety and efficacy of peritoneal dialysis (PD) after graft loss compared with transplant-naive PD patients (TN-PD). Method This study was conducted on 715 patients who started PD between 1988 and 2009, including 47 who started PD after allograft loss (DAGL-PD) and 668 in the (TN-PD) group. Result The mean ages were 40.8 ± 10.7 in DAGL-PD group and 51.03 ± 14.20 in TN-PD group (P <.01). The most common cause of end-stage renal disease in DAGL was primary glomerulonephritis (76.6{\%}), but it was diabetes mellitus (38.9{\%}) in the TN-PD group (P <.05). Patient survival rates at 1, 5, and 10 years were not different: 100{\%}, 86{\%}, and 57{\%} versus 91{\%}, 70{\%}, and 62{\%}, respectively. PD survival rate at 1, 5, and 10 years did not show significant differences: 98{\%}, 95{\%}, and 88{\%} versus 95{\%}, 80{\%}, and 66{\%}, respectively. The most common causes of death in both groups were infection (DAGL, 26.7{\%}; TN-PD, 24.5{\%}) followed by cardiovascular disease (DAGL, 20.0{\%}; TN-PD, 19.6{\%}); the distribution of causes did not differ significantly (P >.05). Conclusion The clinical outcomes of PD in DAGL group were comparable with those of TN-PD patients. Therefore, PD could be considered as a dialysis modality for patients who experience allograft failure.",
author = "Yang, {K. S.} and Kim, {J. I.} and Moon, {I. S.} and Choi, {B. S.} and Park, {C. W.} and Yang, {C. W.} and YuSeun Kim and Chung, {B. H.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.transproceed.2013.08.080",
language = "English",
volume = "45",
pages = "2949--2952",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "8",

}

The clinical outcome of end-stage renal disease patients who return to peritoneal dialysis after renal allograft failure. / Yang, K. S.; Kim, J. I.; Moon, I. S.; Choi, B. S.; Park, C. W.; Yang, C. W.; Kim, YuSeun; Chung, B. H.

In: Transplantation Proceedings, Vol. 45, No. 8, 01.10.2013, p. 2949-2952.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The clinical outcome of end-stage renal disease patients who return to peritoneal dialysis after renal allograft failure

AU - Yang, K. S.

AU - Kim, J. I.

AU - Moon, I. S.

AU - Choi, B. S.

AU - Park, C. W.

AU - Yang, C. W.

AU - Kim, YuSeun

AU - Chung, B. H.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Background With the increased numbers of kidney transplantations, more patients return to dialysis after graft loss (DAGL). The aim of this study was to investigate the safety and efficacy of peritoneal dialysis (PD) after graft loss compared with transplant-naive PD patients (TN-PD). Method This study was conducted on 715 patients who started PD between 1988 and 2009, including 47 who started PD after allograft loss (DAGL-PD) and 668 in the (TN-PD) group. Result The mean ages were 40.8 ± 10.7 in DAGL-PD group and 51.03 ± 14.20 in TN-PD group (P <.01). The most common cause of end-stage renal disease in DAGL was primary glomerulonephritis (76.6%), but it was diabetes mellitus (38.9%) in the TN-PD group (P <.05). Patient survival rates at 1, 5, and 10 years were not different: 100%, 86%, and 57% versus 91%, 70%, and 62%, respectively. PD survival rate at 1, 5, and 10 years did not show significant differences: 98%, 95%, and 88% versus 95%, 80%, and 66%, respectively. The most common causes of death in both groups were infection (DAGL, 26.7%; TN-PD, 24.5%) followed by cardiovascular disease (DAGL, 20.0%; TN-PD, 19.6%); the distribution of causes did not differ significantly (P >.05). Conclusion The clinical outcomes of PD in DAGL group were comparable with those of TN-PD patients. Therefore, PD could be considered as a dialysis modality for patients who experience allograft failure.

AB - Background With the increased numbers of kidney transplantations, more patients return to dialysis after graft loss (DAGL). The aim of this study was to investigate the safety and efficacy of peritoneal dialysis (PD) after graft loss compared with transplant-naive PD patients (TN-PD). Method This study was conducted on 715 patients who started PD between 1988 and 2009, including 47 who started PD after allograft loss (DAGL-PD) and 668 in the (TN-PD) group. Result The mean ages were 40.8 ± 10.7 in DAGL-PD group and 51.03 ± 14.20 in TN-PD group (P <.01). The most common cause of end-stage renal disease in DAGL was primary glomerulonephritis (76.6%), but it was diabetes mellitus (38.9%) in the TN-PD group (P <.05). Patient survival rates at 1, 5, and 10 years were not different: 100%, 86%, and 57% versus 91%, 70%, and 62%, respectively. PD survival rate at 1, 5, and 10 years did not show significant differences: 98%, 95%, and 88% versus 95%, 80%, and 66%, respectively. The most common causes of death in both groups were infection (DAGL, 26.7%; TN-PD, 24.5%) followed by cardiovascular disease (DAGL, 20.0%; TN-PD, 19.6%); the distribution of causes did not differ significantly (P >.05). Conclusion The clinical outcomes of PD in DAGL group were comparable with those of TN-PD patients. Therefore, PD could be considered as a dialysis modality for patients who experience allograft failure.

UR - http://www.scopus.com/inward/record.url?scp=84886246398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886246398&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2013.08.080

DO - 10.1016/j.transproceed.2013.08.080

M3 - Article

C2 - 24157010

AN - SCOPUS:84886246398

VL - 45

SP - 2949

EP - 2952

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 8

ER -